Im sure it wasnt a light idiotic decision on behalf on management.They have successfully built Nanocelle to confirm its efficacy and practical use. The consolidation was done by design for whatever purpose they intend. For lower price or higher who knows. I'll be a buyer if it goes lower as the solid science behind nanocelle is too good to ignore. Compared to mxc or bot product for example.
- Forums
- ASX - By Stock
- MDC
- Ann: UNSW Medlab Laboratory Collaboration Additional Information
Ann: UNSW Medlab Laboratory Collaboration Additional Information, page-19
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online